Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10027985rdf:typepubmed:Citationlld:pubmed
pubmed-article:10027985lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C0038410lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C0041986lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C0205151lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C0765250lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C1546857lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C1556066lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C1619636lld:lifeskim
pubmed-article:10027985lifeskim:mentionsumls-concept:C1514873lld:lifeskim
pubmed-article:10027985pubmed:issue2lld:pubmed
pubmed-article:10027985pubmed:dateCreated1999-4-29lld:pubmed
pubmed-article:10027985pubmed:abstractTextUridine diphosphate galacturonate 4-epimerases (UDPGLEs) are enzymes that convert UDP-glucuronate into UDP-galacturonate. Although the presence of UDPGLEs has been reported in prokaryoic and eukaryotic organisms, the genes coding for these enzymes are completely unknown. The galacturonic acid-containing capsular polysaccharide of Streptococcus pneumoniae type 1 is synthesized through the action of a specific UDPGLE. We have constructed a defined deletion mutant in the cap1J gene (one of the 15 cap1 genes responsible for the synthesis of the type 1 capsule) that exhibited an unencapsulated phenotype. This mutant was unable to synthesize UDPGLE, suggesting that Cap1J was the type 1-specific UDPGLE of S. pneumoniae. Escherichia coli cells harbouring the recombinant plasmid pRMM38 (cap1J) overproduced a 40 kDa protein, characterized as Cap1J on the basis of the N-terminal amino acid sequence analysis, and expressed high levels of enzymatically active Cap1J epimerase. Cap1J was partially purified, although purification to electrophoretic homogeneity inactivated the enzyme irreversibly. The enzyme has the following characteristics: K(m) for UDP-glucuronate, 0.24 mM; pH optimum, 7.5; equilibrium constant (in the direction of UDP-galacturonate formation), 1.3; and an approximate M(r) of 80,000 for the active form. The Cap1J protein exhibited a fluorescence emission spectrum similar to that of NADH. Upon inactivation with p-hydroxymercuribenzoate, the addition of NAD+ and 2-mercaptoethanol were sufficient to reactivate the enzyme. Among several compounds tested, UDP-galactose and UDP-xylose exhibited the highest inhibition of the UDPGLE activity. Inactivation of UDPGLE activity was also observed in the presence of UMP and several reducing sugars. To our knowledge, this is the first example of a thoroughly molecular characterization of a UDPGLE.lld:pubmed
pubmed-article:10027985pubmed:languageenglld:pubmed
pubmed-article:10027985pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10027985pubmed:citationSubsetIMlld:pubmed
pubmed-article:10027985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10027985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10027985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10027985pubmed:statusMEDLINElld:pubmed
pubmed-article:10027985pubmed:monthJanlld:pubmed
pubmed-article:10027985pubmed:issn0950-382Xlld:pubmed
pubmed-article:10027985pubmed:authorpubmed-author:LópezRRlld:pubmed
pubmed-article:10027985pubmed:authorpubmed-author:GarcíaEElld:pubmed
pubmed-article:10027985pubmed:authorpubmed-author:MuñozRRlld:pubmed
pubmed-article:10027985pubmed:authorpubmed-author:de FrutosMMlld:pubmed
pubmed-article:10027985pubmed:issnTypePrintlld:pubmed
pubmed-article:10027985pubmed:volume31lld:pubmed
pubmed-article:10027985pubmed:ownerNLMlld:pubmed
pubmed-article:10027985pubmed:authorsCompleteYlld:pubmed
pubmed-article:10027985pubmed:pagination703-13lld:pubmed
pubmed-article:10027985pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:meshHeadingpubmed-meshheading:10027985...lld:pubmed
pubmed-article:10027985pubmed:year1999lld:pubmed
pubmed-article:10027985pubmed:articleTitleFirst molecular characterization of a uridine diphosphate galacturonate 4-epimerase: an enzyme required for capsular biosynthesis in Streptococcus pneumoniae type 1.lld:pubmed
pubmed-article:10027985pubmed:affiliationCentro de Investigaciones Biológicas, CSIC, Madrid, Spain.lld:pubmed
pubmed-article:10027985pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10027985pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10027985lld:pubmed